Tags Health & Biotech
Related Insights
Thu 17 Aug 2023
AI and Drug Repurposing: Farewell, serendipity?
Our pledge to make therapies available for patients, faster, and why Artificial Intelligence is the key for small molecule repurposing
Fri 29 Apr 2022
ADMET prediction with Artificial Intelligence : Publication
Peer reviewed publication "Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination"
Mon 14 Mar 2022
Artificial Intelligence for Targeted Protein Degradation
Discover how Kantify’s AI -based drug discovery tool, Zeptomics, accelerates the discovery of promising Targeted Protein Degraders (PROTAC, DUBTAC, LYTAC,...),
Thu 27 May 2021
Key AI Techniques in small molecule screening
Discover the key Artificial Intelligence techniques used for small molecule screening
Tue 15 Dec 2020
Artificial Intelligence (AI) in drug discovery
Discover how Artificial Intelligence is transforming and speeding up drug discovery
Fri 04 Dec 2020
Artificial Intelligence for clinical decision support
Discover Artificial Intelligence-based clinical decision support systems, their benefits and challenges
Thu 05 Nov 2020
The state of Artificial Intelligence in Healthcare in the US
A new database provides an overview of the available Artificial Intelligence-based medical devices and health technologies
Tue 27 Oct 2020
What is Data Augmentation in Machine Learning - Part I
Discover what is data augmentation in Machine Learning, and how it can help solve the problem of imbalanced and/or insufficient dataset
Thu 08 Oct 2020
How is Artificial Intelligence used in cardiology?
Discover the uses of Artificial Intelligence in monitoring and preventing cardiovascular diseases in patients
Mon 07 Sep 2020
The use of Artificial Intelligence in Biomedical Imaging
Artificial Intelligence (AI) is disrupting the field of biomedical imaging. Let's discover why.
Thu 30 Apr 2020
5 Pharma companies using Artificial Intelligence
We take a look at the implementation of Machine Learning in five pharmaceutical companies and examine the AI applications for each company individually
Fri 03 Apr 2020
5 ways AI is used to fight COVID-19
We explain how AI has become one of humans' ace cards in handling the COVID-19 crisis
Fri 03 Apr 2020
5 Biotech Companies using AI to their advantage
We explain how some of the world leaders in the biotechnology industry are using AI to their benefit
Fri 15 Nov 2019
AI Applications in Pharma and Biotech
Over the last years, the use of Artificial Intelligence in pharma and biotech industry is redefining how scientists develop new drugs, tackle disease and more
Related News
Wed 29 Nov 2023
Kantify will use its AI platform to tackle 5 rare diseases
Kantify is selected by the European Commission to perform an unprecedented research project on rare diseases and AI
Thu 05 Oct 2023
Kantify speaking at Slush'D Leuven
Kantify will be speaking in the panel on "AI: redefining business or enhancing roles"
Thu 15 Jun 2023
Presentation at Cafes de L'Innovation
Kantify is invited to present its work on AI for target identification and small molecule prediction at Institut Bordet
Tue 06 Jun 2023
Kantify Nominated as Early Startup to Watch by Sifted
We are featured in Sifted's report "AI-Driven Drug Discovery 2.0" Market Report
Mon 22 May 2023
Pitch and Meet at the Tech.eu Summit
Kantify has been selecting to pitch at the Tech.eu Summit 2023 and will present Zeptomics, its solution for AI powered small molecule discovery
Fri 10 Mar 2023
Portrait in BECI Magazine, Brussels Business
In the March Edition of Brussels Business, a 2 page portrait is dedicated to our CEO and our team
Tue 28 Feb 2023
When AI meets Stem Cells: spotlight on our work with I-Stem
Kantify and I-Stem work together for faster rare disease drug discovery
Mon 06 Feb 2023
Special edition on Artificial Intelligence in La Libre Eco
Kantify in the special edition of La Libre Eco on Artificial Intelligence
Sun 05 Feb 2023
Kantify' CEO interview on TV LN24
Kantify's CEO was invited as "CEO of the week" by Bruno Wattenbergh on LN24
Mon 17 Oct 2022
Kantify & Mcule harness data to accelerate drug discovery
Kantify, using its AI technology for drug discovery and Mcule,with its compound sourcing platform, are collaborating to leverage data for better hit prediction
Tue 09 Aug 2022
Kantify in BX1 show on startups and Artificial Intelligence
Kantify was invited to the special edition of BX-1's Startup Story on Start-Ups and Artificial Intelligence
Mon 01 Aug 2022
Watch replay : AI and Drug Repurposing for Fragile X
Watch the replay of our talk at the FRAXA annual event
Wed 20 Jul 2022
Fragile X Syndrome: Innovative Approaches to Finding a Cure
Join the talk of our CTO at this cornerstone online event of the Fragile-X patient and research communityt
Mon 30 May 2022
Targeted Protein Degradation : Kantify at Proteocure event
Kantify spoke about the latest progress of AI/ML for Degraders at the event of Proteocure
Sat 30 Apr 2022
Webinar replay : AI for in silico drug discovery
Watch the replay of our webinar on Zeptomics, Kantify solution for in silico drug discovery
Wed 13 Apr 2022
Abstract selected for Knowledge For Growth
The Abstract presents how AI can be used to accelerate and derisk lead optimization by predicting ADMET properties and off-target binding scores
Mon 28 Mar 2022
Kantify at the annual event of Brussels' Healthtech cluster
Kantify is speaking at the annual event of the Brussels cluster of healthtech companies
Tue 22 Mar 2022
Unveiling Zeptomics, Kantify’s AI drug discovery technology
Discover the new AI technology that accelerates small molecule and targeted protein degradation discovery
Tue 23 Nov 2021
Kantify will host a webinar on AI and cardiology in practice
As a part of the webinar series on AI & Health, Kantify will host its next webinar titled AI in cardiology: detection and prediction of pathologies
Wed 17 Nov 2021
Meet us at Science for Health 2021
Kantify as an exhibitor on this year’s Science for Health event lead by flanders.bio
Thu 22 Jul 2021
Kantify joins the European Biotechnology Network
Kantify has joined the European Biotechnology Network dedicated to biotechnology and life sciences